As Germany prepares for a mass-immunization against the swine flu, there are growing concerns about the existence of two different shots - one for a selected few and one for the rest of the population.
Germans are skeptical of the swine flu vaccine
In one week's time, Germany is scheduled to begin a mass immunization against the swine flu. But the type of shot a person gets is to depend on their position in society, leading to complaints about a 'second class' swine-flu vaccine.
Politicians, certain government employees and members of the German military are scheduled to receive one type of the swine flu vaccine, while average citizens in Germany are to receive a different one.
The difference between the two vaccines is that the one meant for members of the government is said to have fewer side-effects. It also lacks certain additives which are said to be present in the version for the general population.
A spokesperson for the German interior minister, quoted by the Berliner Zeitung newspaper, said that the vaccines marked for the government were ordered months ago, when there were no clear differences between the two vaccines. She added that the other version was not a second-class vaccine.
According to a separate report in the mass-circulation Bild newspaper, Chancellor Angela Merkel and Health Minister Ulla Schmidt are planning on getting vaccinated with the shot provided to the general population.
"It's the same as the rest," said Schmidt, "safe and effective."
Editor: Chuck Penfold
DW's Ross Dunbar and Jonathan Harding collaborate to type up their top six talking points from all the matchday 16 action in the Bundesliga. From form to defending, there's something for everyone.
Dortmund drew at home against Wolfsburg, but nearly won, while Frankfurt scored two late to draw against Hertha. Gladbach, Schalke, and Leverkusen all won their games.
The Russian Central Bank responded resolutely to the panic selling of the ruble. But a base rate of 17 percent won't help much unless there is a drastic change in Kremlin policy, says Andrey Gurkov.